US and Japanese distributors for Raggio-Italgene:
This article was originally published in Clinica
Italy-based Raggio-Italgene has appointed Oncor (US) and Medical & Biological Laboratories (Japan) as exclusive distributors of its C-Trak kits for lymphoma and leukaemia. Oncor's oncology marketing manager, David Parker, says the C-Trak DNA-probes complement its clinical and research products. MBL, which produces antibodies and antisera, immunoassays and reagents for autoantibodies and plasma proteins, says the agreement will enable it to enter the cancer field. In addition to its marketed C-Trak products for lymphoma, leukaemia and cystic fibrosis, Raggio is developing probes for prostate and breast cancer, ss-thalassaemia and several infectious diseases. The Italian company expects to appoint an exclusive distributor for Europe soon.